Six-month liver-health shot, shipped in five days.
A Bangalore-based D2C wellness brand came to Bettrlabs with a failed v1 — two rounds of FSSAI rework, an exhausted budget, and a product window closing. Five business days later, they walked out with first-pass clearance and a manufacturer-ready spec.
Two failed regulatory rounds. One closing launch window.
The brand had already spent eleven weeks and ₹6L on a traditional CRO. V1 of their silymarin + choline shot failed FSSAI on claim substantiation. V2 failed again — this time on the binding agent. The Ayurvedic marketing angle needed a Diwali launch that was six weeks away.
The founder reached out on a Monday. By Friday of the following week, they had a manufacturer-ready spec, a signed regulatory letter, and three lab quotes to choose from.
Compliance-first, not compliance-last.
The agents treated FSSAI clearance as a constraint on the formulator from minute one — not a post-hoc validation. The Brand DNA graph pulled prior passes from 23 adjacent hepato-protective formulations to pre-validate the claim stack. The COGS model landed at ₹38/unit at 10K batch — 18% below the original target.
Brief + graph stand-up
18-min brief. Private Brand Library initialized with prior v1/v2 failure learnings.
Agents run
Formulator v1 → compliance validated → COGS modeled → 5 labs short-listed.
Hand-off
Spec sheet signed. FSSAI clearance letter delivered. Pilot booked at Pune partner.
Launched on Diwali. Shipped 40K units in Q4.
"We were six weeks from a launch that was already two months late. Bettrlabs didn't just save the window — they saved the product. First-pass FSSAI clearance on a formula that had failed twice. I still don't fully believe it happened in five days."
Save the window.
Ship the product.
Your first Quick Check is free — same-day Brand Fit Score, regulatory traffic light, and indicative cost band.